For Glori Energy, the days of operating as a functioning business are long gone. The company now exists as a...
The standalone existence of Alset Capital Acquisition Corp. has officially concluded following the completion of its planned business combination. The...
The biopharmaceutical firm Helix BioPharma is intensifying its development of highly targeted cancer treatments. Recent data presentations for its CEACAM6-targeting...
With a current absence of company-specific news for Lottery.com, investor attention has shifted to the broader market environment for digital...
The clinical development pipeline at Avenue Therapeutics is progressing, with recent strategic moves placing several drug candidates in the spotlight....
The investment community is closely monitoring Outlook Therapeutics as it navigates a decisive period for its flagship ophthalmic drug. While...
Following a strategic realignment, IntelGenx is now channeling its efforts toward advancing its product pipeline and expanding manufacturing capabilities. The...
Biodexa Pharmaceuticals is laying the groundwork for a pivotal phase in its development, targeting 2026 with a refreshed strategy. The...
Western Magnesium Corporation has taken a significant step forward in its strategy to produce environmentally sustainable magnesium. The company has...
Microvision has taken decisive steps to solidify its financial position and integrate recent acquisitions, announcing a $43 million capital raise...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com